Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic sclerosis revealing T-cell lymphoma.

M Hasegawa1, S Sato, H Sakai

  • 1Department of Dermatology, Kanazawa University School of Medicine, Kanazawa, Japan.

Dermatology (Basel, Switzerland)
|February 23, 1999
PubMed
Summary

Systemic sclerosis (SSc) co-occurred with T-cell lymphoma in a patient. Chemotherapy led to remission of both lymphoma and skin sclerosis, suggesting a cytokine link.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatocyte growth factor is linked by O-glycosylated oligosaccharide on the alpha chain.

Biochemical and biophysical research communications·1992
Same author

Distribution and possible origins of substance P-containing nerve fibers in the rat liver.

Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft·1992
Same author

CD4 subsets in IgA nephropathy.

The Tokai journal of experimental and clinical medicine·1992
Same author

[Exchangeability of HIV/SIV regulatory genes].

Uirusu·1992
Same author

[Polymorphism of immunoglobulin heavy chain switch region in IgA nephropathy].

Nihon rinsho. Japanese journal of clinical medicine·1992
Same author

Infection of macaque monkeys with a chimeric human and simian immunodeficiency virus.

The Journal of general virology·1992

Area of Science:

  • Immunology
  • Dermatology
  • Oncology

Background:

  • Systemic sclerosis (SSc) is a rare autoimmune disease characterized by skin hardening.
  • Malignant lymphoma is a cancer of the lymphatic system.

Observation:

  • A 43-year-old male presented with sclerodactyly and progressive skin sclerosis.
  • Subcutaneous tumors developed on the neck, chest, and back, correlating with skin sclerosis.
  • Tumors were diagnosed as T-cell non-Hodgkin's lymphoma.

Findings:

  • The patient achieved complete remission after four cycles of chemotherapy.
  • Remarkable improvement in skin sclerosis was observed post-chemotherapy.
  • Cytokines produced by lymphoma cells may have driven SSc development.

Implications:

  • This case suggests a potential link between T-cell lymphoma and systemic sclerosis.
  • Cytokine-mediated pathogenesis is a plausible mechanism for SSc in this context.
  • Further research into lymphoma-cytokine interactions in SSc is warranted.

Related Experiment Videos